Liaoning Cheng Da Co Ltd (SHG:600739) — Market Cap & Net Worth
Market Cap & Net Worth: Liaoning Cheng Da Co Ltd (600739)
Liaoning Cheng Da Co Ltd (SHG:600739) has a market capitalization of $2.66 Billion (CN¥18.20 Billion) as of May 2, 2026. Listed on the SHG stock exchange, this China-based company holds position #5311 globally and #1060 in its home market, demonstrating a 2.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Liaoning Cheng Da Co Ltd's stock price CN¥11.90 by its total outstanding shares 1529709816 (1.53 Billion). Analyse 600739 cash flow metrics to see how efficiently the company converts income to cash.
Liaoning Cheng Da Co Ltd Market Cap History: 2015 to 2026
Liaoning Cheng Da Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $4.79 Billion to $2.66 Billion (-2.17% CAGR).
Index Memberships
Liaoning Cheng Da Co Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Shanghai Shenzhen CSI 300
CSI300
|
$4.18 Trillion | 0.06% | #197 of 285 |
Weight: Liaoning Cheng Da Co Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Liaoning Cheng Da Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Liaoning Cheng Da Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.21x
Liaoning Cheng Da Co Ltd's market cap is 0.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
11.06x
Liaoning Cheng Da Co Ltd's market cap is 11.06 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.79 Billion | $9.14 Billion | $514.50 Million | 0.52x | 9.31x |
| 2016 | $3.81 Billion | $8.75 Billion | $947.80 Million | 0.44x | 4.02x |
| 2017 | $3.73 Billion | $14.00 Billion | $1.45 Billion | 0.27x | 2.58x |
| 2018 | $2.24 Billion | $19.28 Billion | $770.27 Million | 0.12x | 2.91x |
| 2019 | $3.27 Billion | $17.75 Billion | $1.19 Billion | 0.18x | 2.75x |
| 2020 | $5.25 Billion | $16.94 Billion | $2.77 Billion | 0.31x | 1.89x |
| 2021 | $4.25 Billion | $18.37 Billion | $2.16 Billion | 0.23x | 1.97x |
| 2022 | $2.79 Billion | $14.56 Billion | $1.22 Billion | 0.19x | 2.28x |
| 2023 | $2.64 Billion | $10.78 Billion | $233.08 Million | 0.24x | 11.31x |
| 2024 | $2.32 Billion | $11.29 Billion | $209.56 Million | 0.21x | 11.06x |
Competitor Companies of 600739 by Market Capitalization
Companies near Liaoning Cheng Da Co Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Liaoning Cheng Da Co Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #246 globally with a market cap of $99.71 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #441 globally with a market cap of $59.14 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #570 globally with a market cap of $45.94 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1111 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #246 | McKesson Corporation | NYSE:MCK | $99.71 Billion | $814.02 |
| #441 | Cencora Inc. | NYSE:COR | $59.14 Billion | $304.00 |
| #570 | Cardinal Health Inc | NYSE:CAH | $45.94 Billion | $195.24 |
| #1111 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
Liaoning Cheng Da Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Liaoning Cheng Da Co Ltd's market cap moved from $4.79 Billion to $ 2.66 Billion, with a yearly change of -2.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.66 Billion | +6.44% |
| 2025 | CN¥2.50 Billion | +8.02% |
| 2024 | CN¥2.32 Billion | -12.14% |
| 2023 | CN¥2.64 Billion | -5.43% |
| 2022 | CN¥2.79 Billion | -34.46% |
| 2021 | CN¥4.25 Billion | -18.91% |
| 2020 | CN¥5.25 Billion | +60.52% |
| 2019 | CN¥3.27 Billion | +45.60% |
| 2018 | CN¥2.24 Billion | -39.85% |
| 2017 | CN¥3.73 Billion | -2.00% |
| 2016 | CN¥3.81 Billion | -20.53% |
| 2015 | CN¥4.79 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Liaoning Cheng Da Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.66 Billion USD |
| MoneyControl | $2.66 Billion USD |
| MarketWatch | $2.66 Billion USD |
| marketcap.company | $2.66 Billion USD |
| Reuters | $2.66 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Liaoning Cheng Da Co Ltd
Liaoning Cheng Da Co., Ltd. engages in biopharmaceutical, financial investment, supply chain, energy development, and other businesses in China and internationally. The company is involved in the import and export of textiles, and clothing, as well as the trade of bulk commodities, such as coal, steel, and aquatic products; and oil shale mining, shale oil production, and sale business. It also of… Read more